Five-year supply agreement for Opticore kits through Gurit will streamline the OEM’s process, reduce complexity and unify ...

The Startup Booster brings together 20 finalists selected from more than 160 global applicants to present their innovations ...

Months after announcing a new program to validate self-reported nursing home quality data, the Centers for Medicare & ...

AI and BI are no longer separate conversations-they're converging into a more powerful discipline that's redefining the analytics landscape.

RDAbbott will launch its 2026 webinar series with a live online presentation focused on advanced silicone material ...

MakeMyTrip Limited plans to report its fiscal 2026 third quarter financial and operating results before markets open on ...

As we move deeper into this decade, the question “Should we invest in research?” is becoming “How do we weave market ...

CVSA's five-day Human Trafficking Awareness Initiative kicks off today across the United States, with law enforcement and ...

Leaders should spend intentional one-on-one time on the shop floor to understand work realities and build trust. Encouraging ...

Xenon Pharmaceuticals Inc. Phase 3 X-TOLE2 topline data for azetukalner in FOS expected March 2026 followed by anticipated NDA submission in H2 2026. Five additional Phase 3 azetu ...

Relativity's generative AI case intelligence solution, aiR for Case Strategy, launched for general availability today. aiR ...

DENVER, CO / ACCESS Newswire / January 12, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central n ...